Other rare predicted loss-of-function variants in ANGPTL4 are also associated with lower risk of type 2 diabetes, providing additional allelic evidence that genetic loss of ANGPTL4 function improves glucose homeostasis in humans. This evidence concerns the gene ANGPTL4 and type 2 diabetes mellitus.